Insider trade

Lyell Immunopharma (LYEL)CFO bought ~$112K

Charles W. Newton, CFO at Lyell Immunopharma, bought ~$112K of Lyell Immunopharma shares.

~$112K
Approx. value · 200K sh @ $0.5581
200K
Holds after · shares reported
Traded
Mar 17, 2025
Filed
Mar 18, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 14, 2025Insider · 2 peopleInsiders: 2 purchases (~$201K)
  2. Mar 17, 2025 · this disclosureInsiderCFO purchased ~$112K of LYEL shares in the open market

What came next

  1. Mar 21, 2025InsiderDirector purchased ~$115K of LYEL shares in the open market
  2. Mar 31, 2025InsiderDirector purchased ~$20K of LYEL shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Lyell Immunopharma

OQRO holds no insider, Congress, fund or contract record for Lyell Immunopharma dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LYEL page.

Other recent filings by Charles W. Newton, Chief Financial Officer

The full history of Charles W. Newton, Chief Financial Officer is on the profile page.

How this filing works

Other disclosures at Lyell Immunopharma

Everything OQRO holds on this company is on its LYEL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data